Pinnacle Associates’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-619
| Closed | -$2.05K | – | 777 |
|
|
2022
Q4 | $2.05K | Sell |
619
-26,956
| -98% | -$89.4K | ﹤0.01% | 758 |
|
|
2022
Q3 | $136K | Sell |
27,575
-2,759
| -9% | -$13.6K | ﹤0.01% | 710 |
|
|
2022
Q2 | $230K | Sell |
30,334
-162
| -0.5% | -$1.23K | 0.01% | 670 |
|
|
2022
Q1 | $486K | Sell |
30,496
-1,073
| -3% | -$17.1K | 0.01% | 567 |
|
|
2021
Q4 | $583K | Sell |
31,569
-631
| -2% | -$11.7K | 0.01% | 532 |
|
|
2021
Q3 | $985K | Sell |
32,200
-1,074
| -3% | -$32.9K | 0.02% | 444 |
|
|
2021
Q2 | $1.83M | Buy |
33,274
+498
| +2% | +$27.3K | 0.03% | 347 |
|
|
2021
Q1 | $1.94M | Buy |
32,776
+1,373
| +4% | +$81.1K | 0.04% | 327 |
|
|
2020
Q4 | $1.18M | Sell |
31,403
-7,378
| -19% | -$277K | 0.02% | 376 |
|
|
2020
Q3 | $2.09M | Sell |
38,781
-1,366
| -3% | -$73.8K | 0.05% | 270 |
|
|
2020
Q2 | $10.1M | Sell |
40,147
-646
| -2% | -$163K | 0.25% | 110 |
|
|
2020
Q1 | $6.41M | Buy |
+40,793
| New | +$6.41M | 0.19% | 130 |
|